MAPT and Alzheimer disease: Sonawane and Chinnathambi's [91] study indicated the upregulation of GSK3β promoter demethylation expression and the downregulation of PP2A promoter methylation in the AD brain, both of which accelerated tau phosphorylation (Figure 1).